Keep Factually independent

Whether you agree or disagree with our analysis, these conversations matter for democracy. We don't take money from political groups - even a $5 donation helps us keep it that way.

Loading...Goal: 1,000 supporters
Loading...

What filings list Ben Carson as an officer, director, or advisor of Neurocept LLC?

Checked on November 19, 2025
Disclaimer: Factually can make mistakes. Please verify important info or breaking news. Learn more.

Executive summary

Available sources do not include any SEC, state business filing, or corporate disclosure that explicitly lists Ben Carson as an officer, director, or advisor of an entity named “Neurocept LLC”; reporting instead shows Carson’s documented paid roles with other health-related companies (for example, Galectin Therapeutics lists him as a special consultant) and repeated media discussion of Carson’s name appearing in supplement marketing [1] [2] [3]. TrustPilot and consumer complaints allege Neurocept used images or likenesses of “Dr. Ben Carson” in marketing, but those items are customer reviews or secondary complaints, not formal corporate filings [4].

1. What the available filings and corporate pages actually show

There are no provided filings in the search results that put Ben Carson on the record as an officer, director, or advisor of Neurocept LLC; the only concrete corporate engagement in the results is Galectin Therapeutics identifying Carson as a “special consultant” on its investor page [1] [2]. The Neurocept-related documents in the results are consumer reviews and advertising-critique pages (Trustpilot) rather than state incorporation records, SEC filings, or company “About/Board” pages that would list officers or directors [4].

2. Consumer complaints and marketing claims versus formal corporate disclosure

Trustpilot reviews and consumer columns allege Neurocept used well-known personalities, including “Dr. Ben Carson,” in promotional materials and that some video content may have been AI-generated or misleading; such consumer-facing claims can indicate an association in marketing materials but do not equal a corporate filing or legal officer/director appointment [4]. Journalistic columns and MedCity News reporting from earlier years document Carson’s name being used in supplement marketing (Mannatech) and note disputes over whether he was a paid spokesperson or officially affiliated—again, marketing appearance differs from being an officer or board member in a corporate filing [3] [5].

3. Where reporters have found Carson’s name attached to companies

The clearest example in the search set of a formal company disclosure naming Carson in an advisory or consultant capacity is Galectin Therapeutics’ investor materials and related press coverage that describe him as a “special consultant” tasked with awareness and advisory activities [1] [2]. That is a documented corporate engagement in the available sources; by contrast, no similar corporate documentation for Neurocept LLC appears in the results provided to me [1] [2].

4. Past patterns that matter for assessing the Neurocept question

Reporting and commentary show a pattern where Carson’s public image has been used in supplement advertising and some companies have removed or disavowed association when scrutiny arose (Mannatech episode), suggesting the possibility that a company might feature him in marketing without formal officer/director status [3] [5]. Consumer reviewers explicitly allege Neurocept employed “nationally recognized personalities, like Dr. Ben Carson,” and that marketing materials might have been AI-generated, but those are allegations in reviews and not legal filings [4].

5. What’s missing from the provided evidence

State business registrations (e.g., Louisiana or other secretary of state records), Neurocept LLC corporate statements, SEC filings (if a parent or related company were public), and any signed press releases naming Carson as an officer, director, or paid advisor are not present in the supplied search results. Therefore, available sources do not mention any corporate filing that lists Ben Carson as an officer, director, or advisor of Neurocept LLC (not found in current reporting) [4] [1].

6. How you can confirm the claim conclusively (next steps)

To verify officially, check (a) Neurocept LLC’s state registration and officer filings at the secretary of state where it is incorporated (the Trustpilot review gives a Louisiana address for Neurocept but that is a consumer claim, not an official filing) [4]; (b) any press releases or investor relations pages from Neurocept or a parent company; and (c) searchable federal disclosures or Form 4/8-K/DEF 14A if any public company lists an affiliation. The current search results provide consumer complaints and third‑party reporting about other companies but do not furnish those primary filings [4] [1] [3].

Limitations and competing viewpoints: the Trustpilot review and columns argue Neurocept used Carson’s likeness in deceptive marketing [4] [5]; corporate investor materials for Galectin Therapeutics document an explicit consultant relationship [1] [2]. Neither the consumer allegations nor the Galectin materials substitute for an authoritative Neurocept LLC filing naming Carson as an officer, director, or advisor—such a filing is not present in the supplied sources [4] [1].

Want to dive deeper?
What corporate filings list Ben Carson as an officer, director, or advisor of Neurocept LLC at the state level?
Are there federal SEC or PAC disclosures that mention Ben Carson’s role with Neurocept LLC?
Which states’ business registries or annual reports include Ben Carson linked to Neurocept LLC?
Has Ben Carson been listed as an officer, director, or advisor for Neurocept LLC in court filings or litigation documents?
What press releases, company filings, or lobbying disclosures reference Ben Carson’s affiliation with Neurocept LLC?